BioNeutral Group Inc. | Income Statement
Fiscal year is November-October. All values USD Thousands.
2009
2010
2011
2012
2013
Sales/Revenue
2.80
15.50
53.60
4.60
21.30
Cost of Goods Sold (COGS) incl. D&A
633.20
709.00
727.50
1,188.20
1,418.30
Gross Income
630.40
693.50
673.90
1,183.60
1,397.00
SG&A Expense
6,918.30
3,052.90
2,230.60
1,356.70
1,669.10
EBIT
7,548.70
3,746.40
2,904.50
2,540.30
3,066.20
Unusual Expense
8,052.30
-
-
-
617.90
Non Operating Income/Expense
2.90
-
-
-
-
Interest Expense
-
86.90
156.30
66.00
742.50
Pretax Income
15,598.20
3,833.30
3,060.70
2,606.40
3,190.80
Consolidated Net Income
15,598.20
3,833.30
3,060.70
2,606.40
3,190.80
Net Income
13,451.30
3,501.60
2,819.00
2,386.40
2,921.50
Net Income After Extraordinaries
13,451.30
3,501.60
2,819.00
2,386.40
2,921.50
Net Income Available to Common
13,451.30
3,501.60
2,819.00
2,386.40
2,921.50
EPS (Basic)
0.27
0.06
0.04
0.02
0.02
Basic Shares Outstanding
48,980.20
62,813.10
77,649.50
113,401.40
147,848.50
EPS (Diluted)
0.27
0.06
0.04
0.02
0.02
Diluted Shares Outstanding
48,980.20
62,813.10
77,649.50
113,401.40
147,848.50
EBITDA
6,921.40
3,049.70
2,197.60
1,831.40
2,357.20
Minority Interest Expense
2,146.80
331.70
241.70
220.00
269.30
About BioNeutral Group
View Profile
